Hyperuricemia: all 221 studies
Page 2 of 3. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.
- A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic HyperuricemiaCompletedNCT05302388Phase 1
- Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous GoutCompletedNCT05253833Phase 2
- Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD IndividualsStatus unknownNCT05245890
- Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia VolunteersStatus unknownNCT05226013Phase 1
- Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 TabletsCompletedNCT05168683Phase 1
- Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout PatientsCompletedNCT05119686Phase 2
- Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney DiseaseTerminatedNCT04987294Phase 2
- An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)CompletedNCT04987242Phase 2
- Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female SubjectsCompletedNCT04966325Early Phase 1
- Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of GoutStatus unknownNCT04953533
- Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C)CompletedNCT04938024Not applicable
- Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy AdultsCompletedNCT04886050Phase 1
- Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)CompletedNCT04829435Phase 1
- Vegan Diet, Amla Fruits and Uric AcidCompletedNCT04801745Not applicable
- Hyperuricemia and Diabetic NephropathyStatus unknownNCT04799925
- Treat-to-target by Email During Urate-lowering Therapy in GoutActive, not recruitingNCT04733079Not applicable
- A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or HyperuricemiaCompletedNCT04638543Phase 2
- A Safety and Tolerability Study of FCN-207 in Healthy VolunteersCompletedNCT04622124Phase 1
- Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy VolunteersStatus unknownNCT04586803Phase 1
- Xanthine Oxidase and Uric Acid Origin in Preeclamptic WomenStatus unknownNCT04463940
- Effects of Barley Green in Patients With HyperuricemiaStatus unknownNCT04438486Not applicable
- Effect of Oxalate and Urate Metabolism on CKD EvolutionStatus unknownNCT04399915
- Role of Uralyt-U in Patients With HyperuricemiaStatus unknownNCT04352153Not applicable
- Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute LeukemiaCompletedNCT04349306Phase 4
- ALLN-346 Single Ascending Dose (SAD) Study in Healthy VolunteersCompletedNCT04236219Phase 1
- A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With HyperuricemiaStatus unknownNCT04180982Phase 2
- Effect of the Consumption of a Combination of Plant Extracts (BSL_EP026) on Serum Uric Acid.CompletedNCT04165499Early Phase 1
- Nutraceutical on HyperuricemiaCompletedNCT04161872Phase 4
- The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With HyperuricemiaStatus unknownNCT04157959Phase 1
- The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy AdultsCompletedNCT04139824Phase 1
- Post-Authorisation Safety Study of LesinuradWithdrawnNCT04072471
- Mass Balance Study of [14C]LC350189 in Healthy VolunteersCompletedNCT04070846Phase 1
- Renal PK Study of LC350189CompletedNCT04066712Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671CompletedNCT04060173Phase 1
- Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout PatientsCompletedNCT04040816Phase 2
- Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no SymptomsStatus unknownNCT04012294Phase 3
- The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.CompletedNCT03927677Phase 1
- D-0120 Safety and PK/PD Study in ChinaCompletedNCT03923868Phase 1/2
- Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.CompletedNCT03921736Phase 4
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy SubjectsCompletedNCT03906006Phase 1
- Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout PatientsCompletedNCT03857165Phase 1
- The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease（AURORA）Status unknownNCT03691688
- Tart Cherry Juice and Markers of Inflammation, CVD, and DiabetesCompletedNCT03636529Not applicable
- Urate Lowering Therapies and Left Ventricular Diastolic DysfunctionStatus unknownNCT03534037Phase 4
- Hyperuricemia and Left Ventricular Diastolic FunctionTerminatedNCT03495999
- The Relationship Among, Serum Uric Acid, Left Ventricular Hypertrophy and Metabolic SyndromeStatus unknownNCT03473951
- Prevalence of Hyperuricemia in PakistanStatus unknownNCT03473444
- Effect of Hyperuricaemia on Chronic Renal DiseaseStatus unknownNCT03425708Phase 4
- Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)CompletedNCT03375632Phase 1
- Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03372200Phase 3
- The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF)Status unknownNCT03336203Phase 4
- The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or GoutStatus unknownNCT03306758Not applicable
- The Intervention of Multi-vitamin With Minerals to HyperuricemiaStatus unknownNCT03218709Phase 4
- Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid LevelCompletedNCT03211403Phase 1
- Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis PatientsStatus unknownNCT03200210Phase 4
- Dose-finding and Safety Study of SHR4640 in Subjects With HyperuricemiaCompletedNCT03185793Phase 2
- Use of Febuxostat in Hyperuricemia Among Hemodialysis PatientsCompletedNCT03149939Not applicable
- Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03100318Phase 3
- Gender Differences in the Metabolic Effects of Uric AcidWithdrawnNCT03076684Early Phase 1
- Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03006445Phase 3
- Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese PatientsStatus unknownNCT02944214Not applicable
- The Effects of Rhus Coriaria L. on Serum Uric Acid LevelsStatus unknownNCT02891031Not applicable
- Multiple Dose Study of SHR4640 in Healthy SubjectsCompletedNCT02890966Phase 1
- Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)CompletedNCT02837198Phase 2
- Single Dose Study of SHR4640 in Healthy SubjectsCompletedNCT02815839Phase 1
- Zurig (Febuxostat) 40mg Efficacy and Safety TrialCompletedNCT02600780Phase 4
- Study of URC102 to Assess the Safety and Efficacy in Gout PatientsCompletedNCT02557126Phase 2
- Musculoskeletal Ultrasound in Asymptomatic HyperuricemiaStatus unknownNCT02502565
- Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT02416167Phase 2
- Genetics of Hyperuricemia Therapy in HmongCompletedNCT02371421
- Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT02344862Phase 2
- Compare the Renal Protective Effects of Febuxostat and BenzbromaroneCompletedNCT02338323Not applicable
- The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis PatientsCompletedNCT02338128
- Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without GoutCompletedNCT02327754Phase 2
- A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia PatientsCompletedNCT02317861Phase 1/2
- Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout PatientsCompletedNCT02290210Phase 2
- Long-term Prednisone Use for End-stage Heart FailureStatus unknownNCT02282683Phase 2/3
- the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and HyperuricemiaTerminatedNCT02279342Phase 4
- Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With GoutCompletedNCT02252835Phase 2
- Effect of Chrysanthemum Flower Oil and Its Dose-dependency on HyperuricemiaCompletedNCT02213562Not applicable
- Phase II Exploratory Clinical Study of KUX-1151CompletedNCT02190786Phase 2
- Prednisone for Heart Failure Patients With HyperuricemiaCompletedNCT02129764Phase 2/3
- Effect of Allopurinol Treatment on Insulin ResistanceStatus unknownNCT02008968Not applicable
- Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDyStatus unknownNCT01984749Not applicable
- Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over TrialCompletedNCT01881919Early Phase 1
- Purine Metabolism Enzyme SNP to Uric Acid ProductionCompletedNCT01830725
- The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic SyndromeStatus unknownNCT01818505
- Impact of Blueberries on Uric Acid and Quality of LifeCompletedNCT01532622Not applicable
- Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and GoutStatus unknownNCT01519687Phase 2
- Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout PatientsCompletedNCT01416402Phase 2
- A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal InsufficiencyCompletedNCT01407874Phase 2
- Effects of Green Tea on Level of Serum Uric Acid in Healthy IndividualsCompletedNCT01363869Not applicable
- Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189CompletedNCT01361646Phase 1
- Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With GoutCompletedNCT01336686Phase 2
- Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to AllopurinolCompletedNCT01265264Phase 2
- Hyperuricemia on Hypertension and Metabolic SyndromeCompletedNCT01157936Phase 2
- Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)CompletedNCT01109121Phase 2
- Study of Tranilast Alone or in Combination With Allopurinol in Subjects With HyperuricemiaCompletedNCT01052987Phase 2
- Safety and Efficacy Study of Intramuscular Uricase-PEG 20Status unknownNCT01038947Phase 1
- Safety and Efficacy Study of Intravenous Uricase-PEG 20Status unknownNCT01021241Phase 1